Articles by tag: mrna-vaccine

mRNA influenza vaccine: reprogramming in 2 weeks

Scientists at Vector have created an mRNA influenza vaccine that can be adapted to a new strain in 14 days. Learn how this will change vaccination. Read more!

mRNA vaccine Moderna against influenza: trials completed

mRNA vaccine Moderna against influenza outperformed traditional vaccines in a trial with 40,000 participants. Learn how this will change the market and when to expect the FDA decision.

SaRNA vaccine for cats: EMA decision as a breakthrough for medicine

EMA has approved the first RNA vaccine for animals. We analyze why this decision opens a new wave in human medicine and changes the market. Get insights.

Moderna vaccine shrank tumors in 83% of melanoma patients

mRNA drug mRNA-4359 with Keytruda showed 83% response and 17% complete remissions. Even PD-L1-negative tumors shrank. Learn how a ready-made vaccine teaches the immune system to attack cancer without personalization.